Torpedo™ Device Includes Pre-Shaped, Pre-Loaded Gelatin Foam, Removing Need for Manual Shaping and Loading
SOUTH JORDAN, Utah – September 13, 2019 – Merit Medical Systems, Inc. (NASDAQ:MMSI), a leading manufacturer and marketer of proprietary devices used primarily in cardiology, radiology, oncology, and endoscopy, announces the commercial launch of Torpedo™, a proprietary gelatin foam indicated for use in the embolization of hypervascular tumors. The Torpedo provides physicians a pre-shaped gelatin foam loaded into a cartridge with an optional blunt stylet, removing the need for manual foam shaping and providing fast and easy attachment to the catheter for delivery.
The Merit Torpedo is easy to prepare and use, requiring only hydration with a 50:50 saline-to-contrast mixture. The product is available in two diameters (2.5 mm and 5.0 mm) and two lengths (10 mm and 20 mm), and is designed for use with a catheter with an inner diameter large enough to allow delivery of the Torpedo to the target vasculature via syringe injection. The gelatin foam in the Torpedo is biocompatible, hydrophilic, and resorbable.
“In the operating room, time and consistency are crucial,” said Fred Lampropoulos, Chairman and CEO of Merit Medical. “The Torpedo device, which includes embolizing gelatin compressed into a cylindrical shape and pre-loaded into a cartridge, will save physicians valuable time and improve material delivery with precision and predictability by eliminating manual cutting and shaping. The Torpedo’s launch exemplifies Merit’s commitment to ongoing innovation in the field of embolotherapy, and we look forward to bringing physicians even more groundbreaking technologies soon.”
The Torpedo’s commercial launch furthers Merit’s legacy of innovation in embolization gelatin technology, following the recent 510(k) clearance of Merit’s EmboCube™. The EmboCube offers uniformly cut cubes of gelatin foam preloaded into a syringe, specifically designed to save time and avoid inconsistent particle sizes associated with manual preparation of gelatin foam sheets. Torpedo and EmboCube, the newest additions to Merit’s suite of microcatheters and embolic products, together address an important market need: reducing surgical time without compromising quality of care.
Founded in 1987, Merit Medical Systems, Inc. is engaged in the development, manufacture and distribution of proprietary disposable medical devices used in interventional, diagnostic and therapeutic procedures, particularly in cardiology, radiology, oncology, critical care and endoscopy. Merit serves client hospitals worldwide with a domestic and international sales force and clinical support team totaling exceeding 300 individuals. Merit employs approximately 6,300 people worldwide with facilities in South Jordan, Utah; Pearland, Texas; Richmond, Virginia; Malvern, Pennsylvania; Rockland, Massachusetts; San Jose and Aliso Viejo, California; Maastricht and Venlo, The Netherlands; Paris, France; Galway, Ireland; Beijing, China; Tijuana, Mexico; Joinville, Brazil; Markham, Ontario, Canada; Melbourne, Australia; Tokyo, Japan; Reading, United Kingdom; Johannesburg, South Africa; and Singapore.
Pascale Communications, LLC